Peck Angela J, Englund Janet A, Kuypers Jane, Guthrie Katherine A, Corey Lawrence, Morrow Rhoda, Hackman Robert C, Cent Anne, Boeckh Michael
Department of Pediatrics, Children's Hospital and Regional Medical Center and University of Washington, Seattle, WA, USA.
Blood. 2007 Sep 1;110(5):1681-8. doi: 10.1182/blood-2006-12-060343. Epub 2007 May 14.
The incidence of respiratory virus infection after hematopoietic cell transplantation (HCT) has probably been underestimated with conventional testing methods in symptomatic patients. This prospective study assessed viral infection episodes by testing weekly respiratory samples collected from HCT recipients, with and without symptoms reported by questionnaire, for 100 days after HCT. Samples were tested by culture and direct fluorescent antibody testing for respiratory syncytial virus (RSV), parainfluenza virus (PIV), and influenza A and B, and by quantitative reverse transcription-polymerase chain reaction for RSV, PIV, influenza A and B, and metapneumovirus (MPV). Of 122 patients, 30 (25%) had 32 infection episodes caused by RSV (5), PIV (17), MPV (6), influenza (3), RSV, or influenza (1). PIV, with a cumulative incidence estimate of 17.9%, was the only virus for which asymptomatic infection was detected. Lower virus copy number in patients with no or one symptom compared with 2 or more symptoms was found for all viruses in all patients (P < .001), with PIV infection having a similar virus-specific comparison (P = .004). Subclinical infection with PIV may help explain why infection-control programs that emphasize symptoms are effective against RSV and influenza but often not against PIV.
在造血细胞移植(HCT)后,采用传统检测方法对有症状患者进行检测,可能低估了呼吸道病毒感染的发生率。这项前瞻性研究通过对HCT受者在移植后100天每周采集的呼吸道样本进行检测,评估病毒感染情况,无论受者是否通过问卷报告有症状。样本通过培养以及呼吸道合胞病毒(RSV)、副流感病毒(PIV)、甲型和乙型流感病毒的直接荧光抗体检测进行检测,同时通过定量逆转录-聚合酶链反应对RSV、PIV、甲型和乙型流感病毒以及偏肺病毒(MPV)进行检测。122例患者中,30例(25%)发生了32次感染,病原体包括RSV(5例)、PIV(17例)、MPV(6例)、流感(3例)、RSV或流感(1例)。PIV的累积发病率估计为17.9%,是唯一检测到无症状感染的病毒。在所有患者中,所有病毒在无或有1种症状的患者中病毒拷贝数均低于有2种或更多症状的患者(P < 0.001),PIV感染也有类似的病毒特异性比较结果(P = 0.004)。PIV的亚临床感染可能有助于解释为什么强调症状的感染控制方案对RSV和流感有效,但对PIV往往无效。